GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fusion Antibodies PLC (LSE:FAB) » Definitions » Receivables Turnover

Fusion Antibodies (LSE:FAB) Receivables Turnover : 1.30 (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Fusion Antibodies Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Fusion Antibodies's Revenue for the six months ended in Sep. 2023 was £0.54 Mil. Fusion Antibodies's average Accounts Receivable for the six months ended in Sep. 2023 was £0.42 Mil. Hence, Fusion Antibodies's Receivables Turnover for the six months ended in Sep. 2023 was 1.30.


Fusion Antibodies Receivables Turnover Historical Data

The historical data trend for Fusion Antibodies's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fusion Antibodies Receivables Turnover Chart

Fusion Antibodies Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only 3.53 6.15 7.35 7.02 5.11

Fusion Antibodies Semi-Annual Data
Mar15 Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.12 1.89 1.87 1.32 1.30

Competitive Comparison of Fusion Antibodies's Receivables Turnover

For the Biotechnology subindustry, Fusion Antibodies's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fusion Antibodies's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Fusion Antibodies's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Fusion Antibodies's Receivables Turnover falls into.



Fusion Antibodies Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Fusion Antibodies's Receivables Turnover for the fiscal year that ended in Mar. 2023 is calculated as

Receivables Turnover (A: Mar. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Mar. 2023 ) / ((Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count )
=2.901 / ((0.776 + 0.36) / 2 )
=2.901 / 0.568
=5.11

Fusion Antibodies's Receivables Turnover for the quarter that ended in Sep. 2023 is calculated as

Receivables Turnover (Q: Sep. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Sep. 2023 ) / ((Accounts Receivable (Q: Mar. 2023 ) + Accounts Receivable (Q: Sep. 2023 )) / count )
=0.541 / ((0.36 + 0.471) / 2 )
=0.541 / 0.4155
=1.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fusion Antibodies  (LSE:FAB) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Fusion Antibodies Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Fusion Antibodies's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Fusion Antibodies (LSE:FAB) Business Description

Traded in Other Exchanges
N/A
Address
1 Springbank Road, Springbank Industrial Estate, Dunmurry, Belfast, GBR, BT17 0QL
Fusion Antibodies PLC offers a range of antibody engineering services for all stages of therapeutic and diagnostic antibody development. It is engaged in the research, development, and manufacturing of recombinant proteins, particularly in the areas of cancer and infectious diseases. Its services include antibody sequencing, antibody humanization, stable cell line development, monoclonal antibody production, and transient protein expression. Geographically company generates the majority of its revenue from North America.

Fusion Antibodies (LSE:FAB) Headlines

From GuruFocus

626 Financial, LLC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 10-21-2022